1. Home
  2. SND vs ALXO Comparison

SND vs ALXO Comparison

Compare SND & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

HOLD

Current Price

$4.76

Market Cap

222.7M

Sector

Industrials

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.96

Market Cap

240.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SND
ALXO
Founded
2011
2015
Country
United States
United States
Employees
318
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.7M
240.8M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
SND
ALXO
Price
$4.76
$1.96
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.50
AVG Volume (30 Days)
271.8K
952.5K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.81%
N/A
EPS Growth
N/A
26.36
EPS
N/A
N/A
Revenue
$330,153,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.03
N/A
52 Week Low
$1.76
$0.41
52 Week High
$5.84
$2.66

Technical Indicators

Market Signals
Indicator
SND
ALXO
Relative Strength Index (RSI) 46.09 55.15
Support Level $4.62 $1.99
Resistance Level $5.69 $2.30
Average True Range (ATR) 0.29 0.16
MACD -0.07 0.03
Stochastic Oscillator 40.57 69.29

Price Performance

Historical Comparison
SND
ALXO

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics. The company has two reportable segments, Sand and SmartSystems. It derives maximum revenue from Sand segment, which includes both frac sand sales and IPS sales. Geographically, the company derives maximum revenue from United States, followed by Canada.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: